Proactive Investors Interview with Brent Barnes
Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology.
continue readingIntelligent Automation – the first US Use of the APAS Independence Delivering Artificial Intelligence for Clinical Microbiology Automation
Dr Glen Hansen's Poster on Intelligent Automation presented at the American Society of Microbiology (ASM) Microbe in…
continue readingEvaluation of APAS® Independence for routine urine culture reading within a private clinical setting
As culture reading can be highly subjective and time-demanding the use of artificial intelligence such as the APAS®…
continue readingLBT Presentation, FNN Investor Event
Our CEO presents on LBT's automated plate reading device for use in laboratories, regulatory clearance in the US and the size of the market opportunity.
continue reading
